- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.02B sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 891.76M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$42.51M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$44.65M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $694.83M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $665.82M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $115.76M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $1.02B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $110.96M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $111.59M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $609.17M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $580.69M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $13.95M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $8.92M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.3B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.25B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.11 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.11 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$81.79M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$100.62M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$118.2M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$134.95M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $29.6M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $11.65M |